Skip to content

Cognitive Impairment screening and outcome cohort study

Cognitive Impairment screening and outcome cohort study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071316
Enrollment
Unknown
Registered
2023-05-11
Start date
2023-05-20
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive impairment

Interventions

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 110 Years

Inclusion criteria

Inclusion criteria: From March 2023, the population of cognitive risk assessment in the First Affiliated Hospital of Wenzhou Medical University and the population participating in the cognitive census of Wenzhou City were selected. 1) Age =45 years old. 2) Clinical presentation: Cognitive decline (impairment of memory, executive, language or visuospatial ability) or abnormal mental behavior, affecting the ability to work or daily life. 3) The subjects had good audio-visual function and language function or could complete the neuropsychological examination after correction. 4) The subjects and those with knowledge can complete the relevant examination and follow-up work. 5) Informed consent was signed by the subjects or their authorized principals.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of stroke and focal neurological signs and neuroimaging findings consistent with cerebral small vessel disease (Fazekas score =2). 2) Presence of other neurological diseases that can cause brain dysfunction (such as depression, brain tumors, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, brain trauma, normal intracranial pressure hydrocephalus, etc.). 3) There are other systemic diseases that can cause cognitive impairment, such as liver dysfunction, renal dysfunction, thyroid dysfunction, severe anemia, folate and vitamin B12 deficiency, specific infections (such as syphilis, HIV), alcohol and drug abuse, etc. 4) There is mental and neurodevelopmental delay. 5) Other conditions exist that are known to cause cognitive impairment. 6) Contraindications to MRI exist. 7) An inability to cooperate in completing a cognitive examination. 8) Refusing to draw blood. 9) The screening period refused to sign informed consent.

Design outcomes

Primary

MeasureTime frame
ApoE;brain magnetic resonance imaging;Laboratory index;Cognitive and living ability assessment questionnaire;

Secondary

MeasureTime frame
Color ultrasound;ambulatory blood pressure;eye-ground photography;

Countries

China

Contacts

Public ContactGaojun Wu

the First Affiliated Hospital of Wenzhou Medical University

2855930357@qq.com+86 137 5871 5199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026